Tiragolumab, CISPLATIN , Tecentriq 1 200 mg concentrate for solution for infusion, GEMCITABINE
WO39613
Phase 1 small_molecule active
Quick answer
Tiragolumab, CISPLATIN , Tecentriq 1 200 mg concentrate for solution for infusion, GEMCITABINE for Urothelial carcinoma (UC) is a Phase 1 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Urothelial carcinoma (UC)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active